-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OhjBK8yCkIOIJJyg4FueoBmn+OdA86JSD6nhmMjr9pbgqIisIayd32KHr2fTesF9 CxbRfHKONEcVGxvOY8r93A== 0000904454-04-000252.txt : 20040423 0000904454-04-000252.hdr.sgml : 20040423 20040423104055 ACCESSION NUMBER: 0000904454-04-000252 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040421 FILED AS OF DATE: 20040423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: NJ FISCAL YEAR END: 0103 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50677 FILM NUMBER: 04749638 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 7325242454 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNICON CORP CENTRAL INDEX KEY: 0001083132 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] BUSINESS ADDRESS: STREET 1: 3401 MASONS MILL RD STREET 2: SUITE 100 CITY: HUNTINGTON VALLEY STATE: PA ZIP: 19006 BUSINESS PHONE: 215 830 0777 X121 4 1 edgar.xml PRIMARY DOCUMENT X0201 4 2004-04-21 0001083132 IMMUNICON CORP IMMC 0000200406 JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 0 0 1 0 Common Stock 2004-04-21 4 C 0 1753236 A 1758236 I By Johnson & Johnson Development Corporation Series E Preferred Stock 2004-04-21 4 C 0 1054853 D Common Stock 703236 0 I By Johnson & Johnson Development Corporation Series F Preferred Stock 2004-04-21 4 C 0 1575000 D Common Stock 1050000 0 I By Johnson & Johnson Development Corporation The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the Reporting Person. All of the outstanding shares of the Issuer's Series E Convertible Preferred Stock were automatically converted on a 1-for-1.5 basis into Common Stock of the Issuer upon the closing of the Issuer's initial public offering. All of the outstanding shares of the Issuer's Series F Convertible Preferred Stock were automatically converted on a 1-for-1.5 basis into Common Stock of the Issuer upon the closing of the Issuer's initial public offering. Michael H. Ullman, Secretary 2004-04-21 -----END PRIVACY-ENHANCED MESSAGE-----